Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. AMD
7. TSLA
8. ACN
9. COHR
10. META

Go back to Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
(NASDAQ: RVMD) Delayed: 192.76 --0 (-0%)
Previous Close $192.76    52 Week High $ 
Open $192.76    52 Week Low $ 
Day High $192.76    P/E N/A 
Day Low $192.76    EPS $ 
Volume 377